The share deal follows VivoPower's August announcement of plans to acquire up to $100 million in Ripple Labs shares as part of an XRP-focused treasury strategy.
Ripple News
VivoPower International disclosed plans Wednesday to originate up to $300 million in Ripple Labs shares for South Korea-based Lean Ventures through a dedicated investment vehicle. The publicly listed energy and digital asset treasury company characterized the equity stake as providing exposure to roughly 450 million XRP valued near $900 million at current prices.
The arrangement sees VivoPower's digital asset unit, Vivo Federation, source Ripple equity for placement into a Lean Ventures-managed vehicle rather than deploying significant balance sheet capital. VivoPower will generate revenue through fees and performance-based compensation linked to assets under management, targeting approximately $75 million in net economic returns over three years.
The share deal follows VivoPower's August announcement of plans to acquire up to $100 million in Ripple Labs shares as part of an XRP-focused treasury strategy. The company positions equity ownership as indirect token exposure rather than holding XRP directly on its balance sheet.
Any returns depend on Ripple's corporate performance, balance sheet composition, and broader market dynamics since the structure involves equity ownership rather than direct token holdings. VivoPower characterizes the shareholdings as providing exposure to underlying XRP based on Ripple's existing token holdings, though the mechanism operates through private company equity.
VVPR stock closed at $2.83 Wednesday, down 11.56% from the prior session on approximately 340,600 shares of volume below the stock's average daily turnover. The sharp single-day decline occurred on relatively light participation following the transaction disclosure.
The arrangement targets South Korean investors seeking indirect crypto exposure through traditional financial instruments amid renewed institutional interest in XRP. Resolution of Ripple's U.S. regulatory dispute and approval of spot XRP exchange-traded funds have reduced legal uncertainty around the asset.
Ripple Labs shares trade on private secondary markets often at a discount to the value of the company's XRP holdings due to limited liquidity compared to publicly listed equities. Share pricing results from individualized deals rather than continuous exchange trading, according to VivoPower advisory board member Adam Traidman's prior statements.
VivoPower cautioned that the transaction remains subject to negotiations, market conditions, and Ripple Labs' share availability. The company does not plan to take direct XRP positions, instead pursuing private equity exposure as a proxy for token appreciation while maintaining a traditional investment structure.
This article contains links to third-party websites or other content for information purposes only (“Third-Party Sites”). The Third-Party Sites are not under the control of CoinMarketCap, and CoinMarketCap is not responsible for the content of any Third-Party Site, including without limitation any link contained in a Third-Party Site, or any changes or updates to a Third-Party Site. CoinMarketCap is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement, approval or recommendation by CoinMarketCap of the site or any association with its operators. This article is intended to be used and must be used for informational purposes only. It is important to do your own research and analysis before making any material decisions related to any of the products or services described. This article is not intended as, and shall not be construed as, financial advice. The views and opinions expressed in this article are the author’s [company’s] own and do not necessarily reflect those of CoinMarketCap.
